Literature DB >> 20040326

Malignant transformation in craniopharyngioma after radiation therapy: a case report and review of the literature.

M Ishida1, M Hotta, A Tsukamura, T Taga, H Kato, S Ohta, Y Takeuchi, S Nakasu, H Okabe.   

Abstract

OBJECTIVE: Craniopharyngioma is a benign epithelial tumor that is thought to arise from the remnant of the Rathke pouch. Malignant transformation in craniopharyngioma is extremely rare. Herein, we report a case of malignant transformation in craniopharyngioma after radiation therapy.
MATERIALS AND METHODS: Histopathological and immunohistochemical analyses were carried out for specimens of the suprasellar tumor (from three resections, with the third surgery performed after radiation therapy).
RESULTS: The resected tumors from the first and second surgeries comprised islands of loosely cohesive aggregates of epithelial cells, so-called stellate reticulum. At the periphery of the nests, palisaded columnar epithelium was observed. Wet keratins were scattered, and few mitotic figures were seen. The third surgical specimen was composed of irregular large nests of basaloid cells that had large, round to oval nuclei with prominent nucleoli, and mitotic figures were frequently seen (21/10 high power fields). In the center of the nests, eosinophilic ghost cells, resembling wet keratin, were observed. Accordingly, the diagnosis of malignant transformation in craniopharyngioma was made. Immunohistochemical studies revealed that the p53 protein was over-expressed in the malignant component, whereas its expression was much lower in the benign component.
CONCLUSIONS: Similar to the ten previously reported cases of malignant transformation in craniopharyngioma, the present case occurred after radiation therapy. p53 protein overexpression was also observed in the earlier cases of malignant craniopharyngioma as well as in the present case (6/6 cases). We concluded that radiation therapy and p53 mutations could be involved in malignant transformation in craniopharyngioma.

Entities:  

Mesh:

Year:  2010        PMID: 20040326     DOI: 10.5414/npp29002

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  7 in total

Review 1.  De novo malignant craniopharyngioma: case report and literature review.

Authors:  Libero Lauriola; Francesco Doglietto; Mariangela Novello; Francesco Signorelli; Nicola Montano; Roberto Pallini; Giulio Maira
Journal:  J Neurooncol       Date:  2010-09-03       Impact factor: 4.130

Review 2.  Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.

Authors:  Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti
Journal:  Neurosurg Rev       Date:  2018-04-17       Impact factor: 3.042

3.  Sequential pathological changes during malignant transformation of a craniopharyngioma: A case report and review of the literature.

Authors:  Tetsuya Negoto; Kiyohiko Sakata; Takachika Aoki; Kimihiko Orito; Shinji Nakashima; Masaru Hirohata; Yasuo Sugita; Motohiro Morioka
Journal:  Surg Neurol Int       Date:  2015-03-30

4.  Pathological and Topographical Classification of Craniopharyngiomas: A Literature Review.

Authors:  James Lubuulwa; Ting Lei
Journal:  J Neurol Surg Rep       Date:  2016-07

5.  Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis.

Authors:  Raid A Jastania; Muhammad Saeed; Hisham Al-Khalidi; Khalid AlQuthami; Tahani H Nageeti; Faisal A Al-Allaf; Kristoffer Valerie; Mohiuddin M Taher
Journal:  Int Med Case Rep J       Date:  2020-04-21

Review 6.  The effect of radiation therapy and chemotherapy on malignant craniopharyngioma: A review.

Authors:  Turki Elarjani; Meshari Rashed Alhuthayl; Hindi Alhindi; Imad N Kanaan
Journal:  Surg Neurol Int       Date:  2021-10-25

Review 7.  Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.

Authors:  Juan Pedro Martinez-Barbera; Cynthia L Andoniadou
Journal:  Stem Cells       Date:  2016-01-13       Impact factor: 6.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.